SCHEMBL21880509

SCHEMBL21880509

[N-]=[N+]=N[C@]1(CO)OC[C@@](F)(c2csc3c(N)nc(F)nc23)[C@@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21880794 0.75 HIF1A (0.33) —
SCHEMBL21880486 0.74 — —
SCHEMBL21250531 0.65 POLRMT (0.32) —
SCHEMBL17465446 0.65 — —
SCHEMBL21614182 0.65 AHCY (0.48) —
SCHEMBL20642796 0.65 — —
SCHEMBL21880797 0.65 HIF1A (0.34) —
SCHEMBL19962800 0.65 — —
SCHEMBL19962232 0.64 HIF1A (0.34) —
SCHEMBL24591623 0.64 HIF1A (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4023650-A1 4'-SUBSTITUTED-FURO[3,2-D]PYRIMIDINE AND -PYRROLO[3,2- D]PYRIMIDINE DERIVATIVES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS Gilead Sciences, Inc. (US) 2022-07-06 — — EP disclosed
EP-3174870-B1 THIENO [3,2-D]PYRIMIDINES, FURO [3,2,D]PYRIMIDINES AND PYRROLO [3,2-D]PYRIMIDINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS GILEAD SCIENCES INC (US) 2020-04-15 — — EP disclosed
Send feedback